Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Damoctocog alfa pegol (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Sponsors Bayer
- 11 Oct 2017 Planned End Date changed from 10 Nov 2017 to 15 Dec 2017.
- 11 Oct 2017 Planned primary completion date changed from 27 Oct 2017 to 30 Nov 2017.
- 21 Jul 2017 Status changed from not yet recruiting to recruiting.